Lincoln Pharmaceuticals Limited — Board Meeting, 22-05-2025: Outcome of Board Meeting

Lincoln Pharmaceuticals has announced a board meeting to approve the financial results for the quarter and half-year. Consolidated total income stood at Rs. 645.71 Cr, with net profit at Rs. 82.44 Cr for FY25, down 12% YoY. EBITDA fell 7.7% to Rs. 123.97 Cr, while EPS was Rs. 41.11. The board proposed an 18% dividend (Rs. 1.80/share). FIIs raised their stake to 5%. The company targets Rs. 750 Cr revenue in FY26, driven by new product launches and overseas expansion.